6H90 Stock Overview
A healthcare technology company, focuses on AI and data science for preventative care. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Healwell AI Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.10 |
| 52 Week High | CA$2.43 |
| 52 Week Low | CA$0.45 |
| Beta | -1.12 |
| 11 Month Change | 42.12% |
| 3 Month Change | -11.29% |
| 1 Year Change | 66.67% |
| 33 Year Change | -5.98% |
| 5 Year Change | n/a |
| Change since IPO | -41.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6H90 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 2.8% | 2.9% | 1.1% |
| 1Y | 66.7% | 14.9% | 7.2% |
Return vs Industry: 6H90 exceeded the German Healthcare industry which returned 14.9% over the past year.
Return vs Market: 6H90 exceeded the German Market which returned 7.2% over the past year.
Price Volatility
| 6H90 volatility | |
|---|---|
| 6H90 Average Weekly Movement | 10.7% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6H90's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 6H90's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 102 | Alex Dobranowski | www.healwell.ai |
Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support platform for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies.
Healwell AI Inc. Fundamentals Summary
| 6H90 fundamental statistics | |
|---|---|
| Market cap | €176.63m |
| Earnings (TTM) | -€13.52m |
| Revenue (TTM) | €17.37m |
10.2x
P/S Ratio-13.1x
P/E RatioIs 6H90 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6H90 income statement (TTM) | |
|---|---|
| Revenue | CA$25.69m |
| Cost of Revenue | CA$14.27m |
| Gross Profit | CA$11.42m |
| Other Expenses | CA$31.41m |
| Earnings | -CA$19.99m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 44.45% |
| Net Profit Margin | -77.83% |
| Debt/Equity Ratio | 20.2% |
How did 6H90 perform over the long term?
See historical performance and comparison